Biocon Malaysia gets UK MHRA approval for new drug product fill-finish unit for insulins

Biocon Ltd on Friday said it has received approval from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) for its new drug product fill-finish unit for Semglee (insulin glargine) at its insulin manufacturing facility in Malaysia.According to a regulatory filing by the company, the…